We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+3.84%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$16.5B
AUM Growth
-$1.93B
(-10%)
Cap. Flow
-$2.26B
Cap. Flow
% of AUM
-13.67%
Top 10 Holdings %
Top 10 Hldgs %
16.19%
Holding
1,547
New
416
Increased
366
Reduced
319
Closed
426
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$233M |
| 2 |
TSMC
TSM
|
+$222M |
| 3 |
Philip Morris
PM
|
+$189M |
| 4 |
Qualcomm
QCOM
|
+$171M |
| 5 |
AstraZeneca
AZN
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$396M |
| 2 |
Citigroup
C
|
+$269M |
| 3 |
Cisco
CSCO
|
+$253M |
| 4 |
Boeing
BA
|
+$166M |
| 5 |
Bank of America
BAC
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.96% |
| 2 | Technology | 21.61% |
| 3 | Consumer Staples | 8.79% |
| 4 | Communication Services | 8.54% |
| 5 | Financials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GSK
GSK
$102B
| $359M | 2.17% |
5,373,961
+3,449,966
| +179% | +$233M |
|
|
2
TSMC
TSM
$2.16T
| $308M | 1.86% |
15,360,769
+12,411,776
| +421% | +$222M |
|
|
3
Vodafone
VOD
$35.1B
| $303M | 1.83% |
8,227,003
-10,281,634
| -56% | -$396M |
|
|
4
AstraZeneca
AZN
$261B
| $290M | 1.75% |
4,465,606
+1,966,979
| +79% | +$127M |
|
5
AbbVie
ABBV
$454B
| $263M | 1.59% |
5,120,982
+1,418,020
| +38% | +$71.7M |
|
6
Gilead Sciences
GILD
$162B
| $249M | 1.51% |
3,515,491
+383,862
| +12% | +$30.1M |
|
|
DTV
7
DELISTED
DIRECTV COM STK (DE)
DTV
| $243M | 1.47% |
3,175,997
-122,085
| -4% | -$8.95M |
|
|
LO
8
DELISTED
LORILLARD INC COM STK
LO
| $229M | 1.39% |
4,242,395
+1,857,185
| +78% | +$93.3M |
|
|
SHPG
9
DELISTED
Shire pic
SHPG
| $219M | 1.32% |
1,471,775
+341,226
| +30% | +$52.6M |
|
|
10
Qualcomm
QCOM
$180B
| $215M | 1.3% |
2,724,871
+2,273,671
| +504% | +$171M |
|
11
Micron Technology
MU
$1.12T
| $208M | 1.26% |
8,807,560
+3,504,898
| +66% | +$83.3M |
|
12
Mastercard
MA
$469B
| $208M | 1.26% |
2,788,771
+1,021,161
| +58% | +$79.8M |
|
13
Biogen
BIIB
$29.6B
| $205M | 1.24% |
670,109
-21,445
| -3% | -$6.81M |
|
|
14
Philip Morris
PM
$298B
| $192M | 1.16% |
+2,344,576
| New | +$189M |
|
|
RAD
15
DELISTED
Rite Aid Corporation
RAD
| $185M | 1.12% |
1,475,992
+130,481
| +10% | +$15.9M |
|
16
HP
HPQ
$22.4B
| $181M | 1.09% |
12,293,537
-8,710,222
| -41% | -$117M |
|
17
AT&T
T
$157B
| $178M | 1.08% |
6,710,886
+2,354,872
| +54% | +$59.1M |
|
18
Ericsson
ERIC
$30.6B
| $177M | 1.07% |
13,281,397
+143,893
| +1% | +$1.8M |
|
19
Comcast
CMCSA
$78.3B
| $165M | 1% |
6,610,294
-159,930
| -2% | -$4.17M |
|
20
Magna International
MGA
$17.9B
| $158M | 0.96% |
3,290,578
+48,434
| +1% | +$2.15M |
|
21
Prudential Financial
PRU
$40.9B
| $150M | 0.91% |
1,773,535
-650,215
| -27% | -$56M |
|
22
Netflix
NFLX
$287B
| $149M | 0.9% |
29,541,820
-11,734,170
| -28% | -$67.2M |
|
|
FRX
23
DELISTED
FOREST LABORATORIES INC
FRX
| $142M | 0.86% |
1,535,541
-243,336
| -14% | -$19.6M |
|
24
iShares MSCI Taiwan ETF
EWT
$10.2B
| $138M | 0.83% |
4,797,104
+3,154,662
| +192% | +$88M |
|
25
Tyson Foods
TSN
$20B
| $138M | 0.83% |
3,132,410
-482,443
| -13% | -$18.3M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2014 Portfolio in Review
As of Q1 2014, Arrowstreet Capital held 1,547 positions worth $16.5B, down 10% from $18.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Arrowstreet Capital withdrew a net $2.26B in Q1 2014, closing 426 positions and reducing 319 holdings. Its most notable exit was GE Aerospace, an estimated $151M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Arrowstreet Capital opened a new position in Philip Morris worth $192M.
- Arrowstreet Capital's largest Q1 2014 buy was Philip Morris: 2,344,576 shares worth $192M.
- Arrowstreet Capital added most to GSK in Q1 2014, an estimated $233M increase.
- Arrowstreet Capital's biggest Q1 2014 reduction was Vodafone, cutting an estimated $396M.
- Arrowstreet Capital fully exited GE Aerospace in Q1 2014, selling an estimated $151M.
- Arrowstreet Capital's ten largest holdings make up 16% of its $16.5B portfolio in Q1 2014.
- Arrowstreet Capital opened 416 new positions and closed 426 in Q1 2014.
- Arrowstreet Capital's portfolio value fell 10% quarter-over-quarter to $16.5B.
Based on Arrowstreet Capital's 13F filing for Q1 2014, filed 15 May 2014.